发明名称 NEW 4-ARYLPIPERAZINES AND 4-ARYLPIPERIDINES, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF DOPAMINE-2-RECEPTORS
摘要 FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to 4-arylpiperazines and 4-arylpiperidines of the formula (I) <EMI ID=0.104 HE=27 WI=75 TI=CHI> where A is N or CH; W is C, SO; R<SP>1</SP>, R - H or C<SB>1-4</SB>-alkyl; n = 0-4; R<SP>3</SP>, R - H, alkyl, OH or taken in common as oxygen present carbonyl-group; R - H, C<SB>1-8</SB>-alkyl, C<SB>1-8</SB>-alkoxy-, nitro-, amino-, C<SB>1-8</SB>-acylamino-group; R - H; R is O, S if W is C; R is O if W is SO (other values see p. 1 of the invention claim) that show inhibitory activity with respect to dopamine-2-receptors. EFFECT: new compounds indicated above, inhibitors of receptors. 35 cl, 8 tbl, 113 ex
申请公布号 RU2139867(C1) 申请公布日期 1999.10.20
申请号 RU19930041055 申请日期 1992.09.11
申请人 MAK NEJLEHB, INK. 发明人 ALLEN B.REJTTS
分类号 A61K31/40;A61K31/403;A61K31/404;A61K31/425;A61K31/4427;A61K31/443;A61K31/445;A61K31/451;A61K31/452;A61K31/4523;A61K31/47;A61K31/472;A61K31/495;A61K31/496;A61K31/505;A61K31/55;A61P1/08;A61P1/10;A61P1/12;A61P9/12;A61P25/00;A61P25/18;C07D;C07D207/08;C07D207/09;C07D207/16;C07D209/08;C07D209/26;C07D211/00;C07D211/16;C07D211/18;C07D211/22;C07D211/30;C07D211/44;C07D211/46;C07D211/60;C07D211/62;C07D211/74;C07D211/76;C07D211/96;C07D213/74;C07D217/06;C07D223/14;C07D225/02;C07D231/38;C07D239/26;C07D239/42;C07D241/02;C07D241/04;C07D249/04;C07D249/08;C07D249/14;C07D275/04;C07D295/00;C07D295/04;C07D295/08;C07D295/12;C07D295/14;C07D295/155;C07D295/192;C07D295/194;C07D295/205;C07D295/26;C07D307/79;C07D317/58;C07D317/66;C07D319/16;C07D319/18;C07D401/06;C07D401/12;C07D403/12;C07D405/04;C07D405/12;C07D405/14;C07D413/12;C07D417/04;C07D491/10;C07D491/113;(IPC1-7):C07D401/06 主分类号 A61K31/40
代理机构 代理人
主权项
地址